Chemours
467 hedge funds and large institutions have $3.6B invested in Chemours in 2023 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 110 increasing their positions, 161 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 453 → 467 (+14)
0.77% less ownership
Funds ownership: 77.68% → 76.91% (-0.77%)
32% less repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 161
Holders
467
Holding in Top 10
5
Calls
$80.1M
Puts
$58.6M
Top Buyers
| 1 | +$76.7M | |
| 2 | +$50.5M | |
| 3 | +$28.5M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.91M |
Top Sellers
| 1 | -$54.5M | |
| 2 | -$31.5M | |
| 3 | -$14.2M | |
| 4 |
Bank of New York Mellon
New York
|
-$12.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$12.1M |